CORDA Investment Management LLC. bought a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,249 shares of the semiconductor company's stock, valued at approximately $1,408,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Bayban purchased a new stake in Lam Research in the fourth quarter valued at about $26,000. Vermillion Wealth Management Inc. purchased a new stake in Lam Research during the 1st quarter worth approximately $26,000. Cedar Mountain Advisors LLC increased its stake in Lam Research by 242.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after purchasing an additional 85 shares in the last quarter. Paladin Partners LLC acquired a new position in Lam Research during the 2nd quarter valued at approximately $26,000. Finally, Mcguire Capital Advisors Inc. purchased a new position in shares of Lam Research in the fourth quarter worth $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: AI and memory demand support the outlook. Spending on AI chips, high-bandwidth memory and advanced DRAM is increasing demand for semiconductor-manufacturing equipment, benefiting Lam Research. Upcoming management presentations could provide additional detail on customer spending trends. Why Is Lam Research Corp LRCX Stock Suddenly Gaining Momentum?
- Positive Sentiment: Fundamentals and earnings expectations remain strong. Lam Research’s latest quarterly results exceeded estimates, with earnings of $1.82 per share versus the $1.69 consensus and revenue of $6.72 billion. Revenue increased 30% year over year, while management’s next-quarter earnings guidance and higher forecasts reinforce expectations for continued growth. 3 Reasons We’re Fans of Lam Research
- Positive Sentiment: Analyst sentiment is generally supportive. Brokerages have assigned Lam Research a consensus “Moderate Buy” rating, and long-term stock coverage highlights record revenue, improving margins and favorable AI-related demand prospects. Lam Research Receives Consensus Rating of Moderate Buy
- Neutral Sentiment: Relative performance is attracting attention. Lam Research has substantially outpaced parts of the broader computer and technology sector, although comparisons with individual peers such as CTS do not by themselves change the company’s earnings outlook. Is Lam Research Stock Outpacing Its Peers?
- Negative Sentiment: Valuation and technical risks remain. The stock has nearly tripled over the past year and trades at a growth-oriented valuation, increasing the risk of profit-taking if semiconductor spending or earnings estimates weaken. Recent technical indicators are mixed rather than uniformly bullish. Lam Research Nearly Triples in a Year
Insider Activity
In other news, insider Ava Harter sold 5,000 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the sale, the insider directly owned 42,462 shares of the company's stock, valued at $12,843,056.52. This represents a 10.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares of the company's stock, valued at approximately $29,192,570. This represents a 17.34% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 77,782 shares of company stock valued at $26,755,370 in the last three months. 0.31% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on LRCX. Jefferies Financial Group set a $335.00 price objective on shares of Lam Research and gave the stock a "buy" rating in a research note on Thursday, July 30th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $320.00 price target on shares of Lam Research in a research report on Thursday, July 30th. Bank of America boosted their price target on Lam Research from $330.00 to $480.00 and gave the company a "buy" rating in a research note on Tuesday, June 23rd. UBS Group cut their price objective on Lam Research from $435.00 to $425.00 and set a "buy" rating on the stock in a report on Tuesday, September 1st. Finally, Cantor Fitzgerald set a $500.00 target price on Lam Research and gave the stock an "overweight" rating in a report on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat.com, Lam Research currently has an average rating of "Moderate Buy" and a consensus target price of $358.97.
Get Our Latest Report on Lam Research
Lam Research Stock Performance
NASDAQ LRCX traded up $12.77 on Tuesday, reaching $320.42. 8,922,415 shares of the company's stock traded hands, compared to its average volume of 10,918,421. The firm has a market cap of $400.95 billion, a price-to-earnings ratio of 55.63, a P/E/G ratio of 1.22 and a beta of 1.85. The stock has a 50 day moving average price of $319.27 and a 200-day moving average price of $292.29. Lam Research Corporation has a fifty-two week low of $104.46 and a fifty-two week high of $438.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.13. The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm's revenue for the quarter was up 30.0% compared to the same quarter last year. During the same period last year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts predict that Lam Research Corporation will post 9.33 EPS for the current fiscal year.
Lam Research Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be issued a dividend of $0.33 per share. This is a positive change from Lam Research's previous quarterly dividend of $0.26. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. Lam Research's payout ratio is presently 18.06%.
About Lam Research
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.